liver cancer

Delcath Systems, Inc. announced preliminary Q3 2025 results, with total CHEMOSAT and HEPZATO KIT revenue reaching $20.5 million and net income at $0.8 million. The company projects full-year revenue between $83 and $85 million, representing a 150% treatment volume increase. Positive adjusted EBITDA and operating cash flow are anticipated for each quarter of 2025. A conference call is scheduled for October 20 to discuss results and the CHOPIN trial. The company focuses on liver cancer therapies, including HEPZATO KIT and CHEMOSAT.

Taiwanese actor Lung Fei, beloved for his role as Wei Xiaobao in “The Deer and the Cauldron,” passed away on June 24th at 76. Hospitalized in February, he was diagnosed with inoperable stage three liver cancer. A memorial service is planned for July 8th. Lung Fei left a significant mark on Asian television with his charismatic performances.